Home/Filings/4/0001181431-05-039401
4//SEC Filing

ROWE COMPANIES 4

Accession 0001181431-05-039401

CIK 0000085417operating

Filed

Jul 7, 8:00 PM ET

Accepted

Jul 8, 2:22 PM ET

Size

19.3 KB

Accession

0001181431-05-039401

Insider Transaction Report

Form 4
Period: 2005-07-07
MORPHIS GENE S
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2005-07-07$3.80/sh+2,500$9,50035,500 total
  • Purchase

    Common Stock

    2005-07-07$3.84/sh+600$2,30436,100 total
  • Purchase

    Common Stock

    2005-07-08$3.90/sh+100$39036,200 total
Holdings
  • Option to purchase

    Exercise: $2.15From: 2005-06-03Exp: 2012-12-03common (1,333 underlying)
    8,000
  • Option to purchase

    Exercise: $1.95From: 2004-07-30Exp: 2012-07-30common (5,000 underlying)
    13,000
  • Common Stock

    33,000
  • Option to purchase

    Exercise: $2.15From: 2004-12-03Exp: 2012-12-03common (1,333 underlying)
    6,667
  • Option to Purchase

    Exercise: $3.96From: 2005-04-07Exp: 2015-04-07common (15,000 underlying)
    40,000
  • Option to purchase

    Exercise: $2.15From: 2003-06-03Exp: 2012-12-03common (1,334 underlying)
    2,668
  • Option to purchase

    Exercise: $2.15From: 2004-06-03Exp: 2012-12-03common (1,333 underlying)
    5,334
  • Option to purchase

    Exercise: $2.15From: 2002-12-03Exp: 2012-12-03common (1,334 underlying)
    1,334
  • Option to purchase

    Exercise: $2.15From: 2003-12-03Exp: 2012-12-03common (1,333 underlying)
    4,001
  • Option to Purchase

    Exercise: $3.00From: 2003-12-01Exp: 2013-12-01common (12,000 underlying)
    25,000

Issuer

ROWE COMPANIES

CIK 0000085417

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0000085417

Filing Metadata

Form type
4
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 2:22 PM ET
Size
19.3 KB